Capricor Therapeutics Inc. (NASDAQ: CAPR) shares jumped 13.54% to $9.73 in Wednesday pre-market trading amid the opening of the World Muscle Society’s 2026 congress, where Capricor’s late-breaking HOPE-3 open-label-extension poster on Deramiocel was available to registered delegates on the virtual platform.
Visit Website
